Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
305 patents granted to the 13 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to QuidelOrtho Corporation’s names, not what it holds today.
Patents granted
305
303 utility, 2 design, 1976 to Dec 31, 2025
Granted in 2025
6
Against 9 in 2024 and 9 in 2023
Applications published
245
6 of them in 2025
Names they are printed under
13
a subsidiary
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Analysis of biological materials21
Measurement6
Computer technology4
Chemical engineering3
Biotechnology3
Medical technology1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name13 counted
Ortho-Clinical Diagnostics, Inc. a subsidiary
US, as the owner printed on each patent
173 granted
57 publishedQUIDEL CORPORATION a subsidiary
US, as the owner printed on each patent
87 granted
37 publishedOrtho-Clinical Diagnostics, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
72 publishedDiagnostic Hybrids, Inc. a subsidiary
US, as the owner printed on each patent. 2 more under the same name are not counted (printed in GR)
33 granted
19 publishedQuidel Corporation a subsidiary
named as the applicant on its applications, in US
0 granted
47 publishedBIO-HELIX CO., LTD. a subsidiary
US, as the owner printed on each patent. 2 more under the same name are not counted (printed in TW)
3 granted
3 publishedQUIDEL CARDIOVASCULAR INC. a subsidiary
US, as the owner printed on each patent
4 granted
2 publishedQuidel Cardiovascular Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
4 publishedImmutopics, Inc. a subsidiary
US, as the owner printed on each patent
3 granted
0 publishedDiagnostic Hybrids, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
2 publishedMicro Typing Systems, Inc. a subsidiary
US, as the owner printed on each patent
2 granted
0 publishedBioHelix Corporation a subsidiary
named as the applicant on its applications, in US. 2 more under the same name are not counted (printed in TW)
0 granted
1 publishedQUIDEL CORPORATION, a Delaware corporation a subsidiary
US, as the owner printed on each patent
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Nov 18, 2025 | 12,474,333 | Interactive test system and method for detecting an analyte | Analysis of biological materials | Ortho-Clinical Diagnostics, Inc. |
| Jul 1, 2025 | 12,345,700 | Device for whole blood separation | Chemical engineering | Ortho-Clinical Diagnostics, Inc. |
| Jun 24, 2025 | 12,339,280 | N-acetyl-D-glucosamine for enhanced specificity of strep a immunoassay | Analysis of biological materials | Ortho-Clinical Diagnostics, Inc. |
| May 13, 2025 | 12,298,251 | System and methods for remote assessment of a sample assay for disease diagnostics | Measurement | Ortho-Clinical Diagnostics, Inc. |
| May 6, 2025 | 12,290,806 | Substrate with channels for controlled fluid flow | Analysis of biological materials | Ortho-Clinical Diagnostics, Inc. |
| Apr 29, 2025 | 12,285,755 | Lateral-flow assay device with filtration flow control | Analysis of biological materials | Ortho-Clinical Diagnostics, Inc. |
| Dec 24, 2024 | 12,174,185 | Compositions and methods for detecting autoantibodies | Analysis of biological materials | QUIDEL CORPORATION |
| Dec 10, 2024 | 12,165,373 | Software and algorithms for use in remote assessment of disease diagnostics | Computer technology | Ortho-Clinical Diagnostics, Inc. |
| Oct 22, 2024 | 12,123,875 | Antigen analogue for calibration of immunometric diagnostic assays | Biotechnology | Ortho-Clinical Diagnostics, Inc. |
| Oct 15, 2024 | 12,117,443 | Immunoassay controls and the use thereof | Analysis of biological materials | QUIDEL CARDIOVASCULAR INC. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Dec 11, 2025 | 2025/0378954 | SYSTEM FOR VISUALIZING AND SUPPORTING A CONTEXTUAL DIAGNOSTIC DECISION FOR CONTAGIOUS DISEASES | Medical technology | Quidel Corporation |
| Oct 30, 2025 | 2025/0334573 | LATERAL FLOW IMMUNOASSAYS COMPRISING FLUIDIC CHANNELS | Analysis of biological materials | Ortho-Clinical Diagnostics, Inc. |
| Jul 31, 2025 | 2025/0246319 | SYSTEM FOR COLLECTING AND DISPLAYING DIAGNOSTICS FROM DIAGNOSTIC INSTRUMENTS | Computer technology | Ortho-Clinical Diagnostics, Inc. |
| Jul 24, 2025 | 2025/0237613 | SYSTEM AND METHODS FOR REMOTE ASSESSMENT OF A SAMPLE ASSAY FOR DISEASE DIAGNOSTICS | Measurement | Ortho-Clinical Diagnostics, Inc. |
| Jul 24, 2025 | 2025/0235860 | SUBSTRATE WITH CHANNELS FOR CONTROLLED FLUID FLOW | Analysis of biological materials | Ortho-Clinical Diagnostics, Inc. |
| Feb 27, 2025 | 2025/0069353 | SOFTWARE AND ALGORITHMS FOR USE IN REMOTE ASSESSMENT OF DISEASE DIAGNOSTICS | Computer technology | Ortho-Clinical Diagnostics, Inc. |
| Nov 14, 2024 | 2024/0377395 | AGGLUTINATING AGENTS, DEVICES AND METHODS FOR WHOLE BLOOD ASSAYS | Analysis of biological materials | Quidel Corporation |
| Sep 19, 2024 | 2024/0310362 | METHOD TO IDENTIFY INDIVIDUALS WITH T CELL IMMUNITY TO SPECIFIC INFECTIOUS AGENTS | Measurement | Quidel Corporation |
| Jul 18, 2024 | 2024/0241025 | IMAGE CAPTURING AND PROCESSING FOR IMMUNOASSAYS | Measurement | Quidel Corporation |
| Jul 11, 2024 | 2024/0230639 | DEVICES AND KITS FOR DETECTING ANALYTES OF INTEREST AND METHODS OF USING THE SAME | Measurement | Quidel Corporation |
What it applied for, 2024 to 2025: Analysis of biological materials 8 · Measurement 6 · Computer technology 2 · Biotechnology 1 · Medical technology 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.